Zomedica Pharmaceuticals Corp. (ZOM)
Seeking Alpha Analyst Since 2018
TradersPro is a trading system used to implement the concepts of trend following. TradersPro is a systematic trading application that searches for qualified, high-ranking stocks, gives traders specific trade entry and exit signals, and provides traders with insight and strategy to confidently trade stocks, and ETFs. It has been proven that traders gain a much higher probability of having successful, profitable trades when trading in the same direction of the market, and when using a fixed set of rules.
Summary
- Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day.
- Target prices for exits can be determined by using the next level of resistance higher or by using Fibonacci resistance levels found using TradersPro.
- Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.
Trade Setup
Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the potential for very sharp moves. A stop should be maintained at the low of the prior day. Target prices for exits can be determined by using the next level of resistance higher or by using Fibonacci resistance levels found using TradersPro.
Hey, do you want to be the next stock market millionaire? This free training lays it all out for you! Check it out here.
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.